Severe traffic injuries in Finland result in major financial burdens, with direct costs dominating within the first year

Phase IIa da­ta for Struc­ture Ther­a­peu­tics’ oral GLP-1 drug can­di­date for type 2 di­a­betes and obe­si­ty best­ed an­a­lyst ex­pec­ta­tions on safe­ty and tol­er­a­bil­i­ty, but low­er-than-hoped-for

Less than 14 months af­ter be­com­ing a stand­alone com­pa­ny, John­son & John­son’s con­sumer health­care spin­out Ken­vue is star­ing down an ac­tivist in­vestor. The in­vestor, Star­board